4[4]BCIBISⅡ Investigation and Committees.The Cardiac Insufficiency bisoprolol study(CIBISⅡ):a randomized trial[J].Lancet,1999,353(1):9-13
二级参考文献26
1Barron HV,Rundle AC,Gore JM,et al.Intracranial hemorrhage rates and effect of immediate beta-blocker use in patients with acute myocardial infarction treated with tissue plasminogen activator.Participants in the National Registry of Myocardial Infarction-
2Harjai KJ,Stone GW,Boura J,et al.Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction.Am J Cardiol,2003,91:655-660.
3Abrams J,Allen J,Allin D,et al.Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias:a multicenter double-blind clinical trial.Am Heart J,1985,110:913-922.
4Mangano DT,Goldman L.Preoperative assessment of patients with known or suspected coronary disease.N Engl J Med,1995,333:1750-1756.
5Poldermans D,Boersma E,Bax JJ,et al.The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery.Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Grou
6Mangano DT,Layug EL,Wallace A,et al.Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.Multicenter Study of Perioperative Ischemia Research Group.N Engl J Med,1996,335:1713-1720.
7Ferguson TB Jr,Coombs LP,Peterson ED.Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America.JAMA,2002,287:2221-2227.
8Auerbach AD,Goldman L.Beta-Blockers and reduction of cardiac events in noncardiac surgery:scientific review.JAMA,2002,287:1435-1444.
9Hjalmarson A,Goldstein S,Fagerberg B,et al.Effects of controlled-release metoprolol on total mortality,hospitalizations,and well-being in patients with heart failure:the Metoprolol GR/XL.Randomized Intervention Trial in congestive heart failure(MERIT-HF).
